VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $981,786 | +13.2% | 227,265 | +72.6% | 0.00% | – |
| Q2 2023 | $867,573 | -38.5% | 131,650 | -36.7% | 0.00% | – |
| Q1 2023 | $1,411,000 | +86199.7% | 207,872 | -6.1% | 0.00% | – |
| Q4 2022 | $1,635 | -99.9% | 221,284 | +50.6% | 0.00% | – |
| Q3 2022 | $1,452,000 | +26.8% | 146,961 | +39.8% | 0.00% | – |
| Q2 2022 | $1,145,000 | -72.2% | 105,112 | -71.1% | 0.00% | – |
| Q1 2022 | $4,114,000 | -24.4% | 363,768 | +4.8% | 0.00% | -100.0% |
| Q4 2021 | $5,444,000 | -9.3% | 347,052 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $5,999,000 | -25.4% | 349,990 | -6.4% | 0.00% | 0.0% |
| Q2 2021 | $8,042,000 | +78.9% | 373,831 | +24.9% | 0.00% | 0.0% |
| Q1 2021 | $4,496,000 | -6.5% | 299,348 | -18.2% | 0.00% | 0.0% |
| Q4 2020 | $4,811,000 | +260.1% | 366,037 | +160.3% | 0.00% | – |
| Q3 2020 | $1,336,000 | -22.8% | 140,602 | -7.1% | 0.00% | – |
| Q2 2020 | $1,731,000 | -3.0% | 151,346 | -12.1% | 0.00% | – |
| Q1 2020 | $1,784,000 | -42.6% | 172,192 | -9.1% | 0.00% | -100.0% |
| Q4 2019 | $3,107,000 | +15.1% | 189,348 | -6.9% | 0.00% | 0.0% |
| Q3 2019 | $2,700,000 | -37.8% | 203,325 | -32.4% | 0.00% | 0.0% |
| Q2 2019 | $4,339,000 | +17.1% | 300,927 | +49.5% | 0.00% | 0.0% |
| Q1 2019 | $3,705,000 | -39.3% | 201,325 | -13.9% | 0.00% | 0.0% |
| Q4 2018 | $6,108,000 | -8.6% | 233,728 | -19.7% | 0.00% | 0.0% |
| Q3 2018 | $6,681,000 | +12.9% | 291,095 | -6.3% | 0.00% | 0.0% |
| Q2 2018 | $5,920,000 | +21.4% | 310,770 | +7.4% | 0.00% | 0.0% |
| Q1 2018 | $4,877,000 | -15.5% | 289,469 | -23.8% | 0.00% | 0.0% |
| Q4 2017 | $5,773,000 | +439.0% | 379,829 | +540.1% | 0.00% | – |
| Q3 2017 | $1,071,000 | -53.1% | 59,338 | -57.7% | 0.00% | -100.0% |
| Q2 2017 | $2,285,000 | +14.9% | 140,173 | -1.3% | 0.00% | – |
| Q1 2017 | $1,989,000 | -30.8% | 142,051 | -21.2% | 0.00% | -100.0% |
| Q4 2016 | $2,876,000 | +12.0% | 180,312 | +16.8% | 0.00% | 0.0% |
| Q3 2016 | $2,568,000 | +228.4% | 154,313 | +120.7% | 0.00% | – |
| Q2 2016 | $782,000 | +39000.0% | 69,912 | +26997.7% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 258 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | – | 258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |